Equities research analysts forecast that Castlight Health Inc (NYSE:CSLT) will report sales of $36.93 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Castlight Health’s earnings, with the lowest sales estimate coming in at $36.11 million and the highest estimate coming in at $38.40 million. Castlight Health posted sales of $29.90 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 23.5%. The business is expected to report its next earnings report on Wednesday, February 21st.
On average, analysts expect that Castlight Health will report full year sales of $36.93 million for the current year, with estimates ranging from $130.53 million to $132.00 million. For the next financial year, analysts expect that the company will report sales of $163.82 million per share, with estimates ranging from $156.40 million to $169.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Castlight Health.
Castlight Health (NYSE:CSLT) last released its earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.02. Castlight Health had a negative net margin of 45.14% and a negative return on equity of 32.57%. The firm had revenue of $34.60 million during the quarter, compared to analyst estimates of $34.61 million. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. The firm’s revenue for the quarter was up 35.7% compared to the same quarter last year.
In related news, President Robert Derek Newell acquired 30,000 shares of Castlight Health stock in a transaction that occurred on Friday, October 27th. The stock was acquired at an average price of $3.95 per share, with a total value of $118,500.00. Following the completion of the acquisition, the president now directly owns 128,671 shares of the company’s stock, valued at approximately $508,250.45. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO John C. Doyle sold 13,686 shares of the company’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the sale, the chief executive officer now directly owns 123,705 shares of the company’s stock, valued at approximately $458,945.55. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,778 shares of company stock valued at $84,411. Corporate insiders own 37.43% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. Voya Investment Management LLC lifted its holdings in Castlight Health by 25.4% in the second quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock worth $112,000 after purchasing an additional 5,453 shares during the period. Nationwide Fund Advisors lifted its holdings in Castlight Health by 49.5% in the 2nd quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock valued at $151,000 after acquiring an additional 12,061 shares during the last quarter. Stifel Financial Corp lifted its holdings in Castlight Health by 12.3% in the 2nd quarter. Stifel Financial Corp now owns 41,000 shares of the software maker’s stock valued at $171,000 after acquiring an additional 4,500 shares during the last quarter. UBS Asset Management Americas Inc. acquired a new stake in Castlight Health in the 2nd quarter valued at about $193,000. Finally, New York State Common Retirement Fund lifted its holdings in Castlight Health by 60.5% in the 2nd quarter. New York State Common Retirement Fund now owns 49,600 shares of the software maker’s stock valued at $206,000 after acquiring an additional 18,699 shares during the last quarter. 42.55% of the stock is owned by institutional investors and hedge funds.
Castlight Health (NYSE:CSLT) traded up $0.15 during mid-day trading on Friday, reaching $3.90. 608,316 shares of the company’s stock traded hands, compared to its average volume of 276,781. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.94 and a quick ratio of 1.94. Castlight Health has a 12-month low of $3.05 and a 12-month high of $5.50.
ILLEGAL ACTIVITY WARNING: This news story was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/12/16/zacks-analysts-anticipate-castlight-health-inc-cslt-will-announce-quarterly-sales-of-36-93-million.html.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Castlight Health? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Castlight Health and related companies.